Inside 3M's Q3 2025 Earnings: Sales Grow, but Profits Fall on Special Charges

Industrial giant 3M has released its third-quarter financial results for 2025, and a dive into its latest 10-Q filing reveals a quarter of solid sales growth and improved operational performance, though the final profit figures are clouded by special charges and divestiture-related losses. Let's break down the key numbers from the income statement.

Solid Sales Growth Across the Board

For the third quarter ending September 30, 2025, 3M reported net sales of $6.5 billion, a 3.5% increase from the same period last year. This growth was primarily driven by a healthy 2.6% rise in organic sales, which measures growth from existing businesses, excluding the effects of currency fluctuations, acquisitions, and divestitures.

Geographically, the company saw strength in its largest markets, with total sales in the United States growing 3.4% and in China/Hong Kong jumping 9.5%.

A breakdown of 3M's performance by business segment shows:

• Safety and Industrial: This largest segment was also the strongest performer, with sales climbing 5.4% to $2.9 billion. The growth was widespread, with notable increases in electrical markets, industrial adhesives, and personal safety products.
• Transportation and Electronics: Sales grew a modest 2.4% to $2.2 billion, helped by gains in commercial branding and electronics.
• Consumer: The segment known for brands like Post-it and Scotch saw sales increase slightly by 0.9% to $1.3 billion, indicating steady but not spectacular performance in a soft consumer spending environment.

Following the Money: From Revenue to Profit

To understand how 3M's revenue translated into profit, the following flow diagram visualizes the company's income statement for the third quarter of 2025.

The "Corporate and Other" revenue line in the diagram, totaling $97 million for the quarter, primarily consists of unallocated corporate activities, transition agreements with divested businesses (like the recently spun-off Solventum), and operations from the former Health Care business that 3M retained.

While sales were up, the bottom line tells a different story. GAAP Net Income attributable to 3M fell to $834 million, or $1.55 per diluted share, a significant drop from last year's $1.37 billion, or $2.48 per share.

So, where did the money go? The discrepancy lies not in the core operations but in special items. Operating income, a measure of profitability from the main business activities, actually increased to $1.45 billion from $1.32 billion a year ago.

The two main drivers behind the lower net income were:

1. Loss on Business Divestitures: 3M recorded a $161 million loss related to the sale of its fused silica business.
2. Other Expense (Income), Net: This line item swung dramatically from a $405 million income last year to a $300 million expense this quarter. A significant portion of this swing is due to the change in value of 3M's retained ownership stake in Solventum, its spun-off healthcare business.

When these and other special items are excluded, 3M's adjusted earnings per share were $2.19, a 10% increase year-over-year. This adjusted figure provides a clearer view of the underlying health of the company's core operations.

Looking Ahead

3M's third-quarter results paint a picture of a company making steady operational progress. The core business segments are growing, and profitability from those operations is improving. However, the headline numbers are heavily impacted by strategic portfolio adjustments, including divestitures and the Solventum spin-off. Investors will be watching to see if this operational strength can continue to shine through as the company navigates these strategic shifts and continues to manage significant ongoing legal challenges related to PFAS chemicals and Combat Arms earplugs.